Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue
Submit an article Journal homepage
150
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

Tingting Che1 Department of Endocrinology, Chongqing Public Health Medical Center, Chongqing, China
,
Xiaochun Teng1 Department of Endocrinology, Chongqing Public Health Medical Center, Chongqing, China
,
Qun Huang1 Department of Endocrinology, Chongqing Public Health Medical Center, Chongqing, China
,
Yanfei Mu2 Chongqing Cancer Institute, Hospital and Cancer Center, Chongqing, China
,
Xianjun Tang2 Chongqing Cancer Institute, Hospital and Cancer Center, Chongqing, China
,
Xiaosong Mu2 Chongqing Cancer Institute, Hospital and Cancer Center, Chongqing, China
&
Youneng Wei1 Department of Endocrinology, Chongqing Public Health Medical Center, Chongqing, ChinaCorrespondence[email protected]
 show all
Pages 1527-1533 | Published online: 13 Jun 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tonatiuh Gonzalez Heredia, Leivy Patricia González-Ramírez, Diana Mercedes Hernández-Corona & Eugenio Alejandro Maciel-Hernández. (2021) Anxious depression in patients with Type 2 Diabetes Mellitus and its relationship with medication adherence and glycemic control. Global Public Health 16:3, pages 460-468.
Read now
Trevor R. Norman & James S. Olver. (2019) Agomelatine for depression: expanding the horizons?. Expert Opinion on Pharmacotherapy 20:6, pages 647-656.
Read now
Tian-ju Wan, Yi-Chuan Yu, Xiao-gang Zhao, Ping Tang & Yong-shu Gong. (2018) Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo. Neuropsychiatric Disease and Treatment 14, pages 2965-2971.
Read now

Articles from other publishers (12)

Nevertyty M. Mahmoud, Shimaa M. Elshazly, Arwa A. Hassan & Eman Soliman. (2023) Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway. International Immunopharmacology 115, pages 109646.
Crossref
Manit Srisurapanont, Sirijit Suttajit, Natapong Kosachunhanun, Surinporn Likhitsathian, Chawisa Suradom & Benchalak Maneeton. (2022) Antidepressants for depressed patients with type 2 diabetes mellitus: A systematic review and network meta-analysis of short-term randomized controlled trials. Neuroscience & Biobehavioral Reviews 139, pages 104731.
Crossref
Zizhen Zhang, Yang Du, Lizhi Chen, Ying Liu & Biao Du. (2022) Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review. Asian Journal of Psychiatry 73, pages 103092.
Crossref
Hans-Peter KapfhammerHans-Peter Kapfhammer. 2022. Depression, Angst, traumatischer Stress und internistische Erkrankungen. Depression, Angst, traumatischer Stress und internistische Erkrankungen 221 287 .
Zihong Liang, Yanbo Jia, Lizhen Zhao, Runxiu Zhu, Xuemei He, Bagen Tong, Fan Yang, Lixia Hao, Pengfei Cui & Jun Yuan. (2021) Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine. Aging 13:19, pages 22934-22946.
Crossref
Vanessa Barbosa Veronesi, Mariana Rodrigues Pioli, Dailson Nogueira de Souza, Caio Jordão Teixeira, Gilson Masahiro Murata, Junia Carolina Santos-Silva, Fernanda Ballerini Hecht, Julia Modesto Vicente, Silvana Bordin & Gabriel Forato Anhê. (2021) Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats. Biomedicine & Pharmacotherapy 141, pages 111807.
Crossref
Christina van der Feltz‐Cornelis, Sarah F. Allen, Richard I. G. Holt, Richard Roberts, Arie Nouwen & Norman Sartorius. (2020) Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta‐analysis. Brain and Behavior 11:2.
Crossref
Shushan Wang, Qing Xu, Kankan Qu, Jun Wang & Zhenhe Zhou. (2021) CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury. Medicine 100:45, pages e27736.
Crossref
Madeline R. Scott & Colleen A. McClung. 2021. Circadian Clock in Brain Health and Disease. Circadian Clock in Brain Health and Disease 153 168 .
Huanping Wang, Huizhen Chen, Yang Gao, Shengju Wang, Xian Wang, Xiaomei Tang, Wei Fang, Xiaoyan Shi, Jia Yao & Qiu Chen. (2020) The effect of wuling capsule on depression in Type 2 diabetic patients. Bioscience Reports 40:2.
Crossref
Aidibai Simayi & Patamu Mohemaiti. (2019) Risk and protective factors of co-morbid depression in patients with type 2 diabetes mellitus: a meta analysis. Endocrine Journal 66:9, pages 793-805.
Crossref
Yu. P. Sivolap. (2018) Antidepressants: the goals and possibilities of therapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:12, pages 120.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.